Cantor Fitzgerald Initiates Coverage On KemPharm With Overweight Rating, Announces Price Target of $20
Cantor Fitzgerald Initiates Coverage On KemPharm With Overweight Rating, Announces Price Target of $20
康託·菲茨傑拉德以增持評級啟動對KemPharm的報道，宣佈目標價為20美元
Cantor Fitzgerald analyst Louis Chen initiates coverage on KemPharm (NASDAQ:KMPH) with a Overweight rating and announces Price Target of $20.
Cantor Fitzgerald分析師Louis Chen在納斯達克(KemPharm)上以增持評級啟動報道，並宣佈目標價為20美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。